Together, these findings predict that a decrease in AMPK activity in susceptible patients may result in an electrophysiological reprogramming of atrial ion channels and gap junction proteins that might promote the development and perpetuation of atrial fibrillation. This evidence concerns the gene PRKAA1 and atrial fibrillation.